CDC officials reported Tuesday that only half of U.S. patients diagnosed with hepatitis C receive follow-up screening to determine if they are still infected. "Complete testing is critical to ensure that those who are infected receive the care and treatment for hepatitis C that they need in order to prevent liver cancer and other serious and potentially deadly health consequences," said CDC Director Dr. Thomas Frieden.
CDC: Incomplete screening common among HCV patients
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|